Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On December 31, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 155 restricted stock units vested and were converted into 155 shares of common stock.
- Following the transaction, Krognes directly owns 10,220 shares of common stock and 2,777 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative implications.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the holdings of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| August 9, 2022 | Date of grant for the restricted stock unit award. |
| June 30, 2023 | 25% of the restricted stock units vested. |
| December 31, 2024 | Date of the reported transaction where 155 restricted stock units vested and were converted to common stock. |
| January 02, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.